Transgenomic, Inc. and ApoCell, Inc. Present Results of Lung Cancer Research Study at the 2013 American Society of Clinical Oncology Annual Meeting

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Transgenomic, Inc. (OTCBB: TBIO) and ApoCell, Inc. today announced the results of a research collaboration with the University of Texas MD Anderson Cancer Center that coupled ApoCell’s ApoStream™ platform for isolating circulating tumor cells (CTCs) with Transgenomic’s ICE COLD-PCR technology to detect signature mutations in CTCs isolated from the blood of lung cancer patients.

Help employers find you! Check out all the jobs and post your resume.